• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Newhall Land & Farming LP

Newhall Land & Farming LP

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Non-Hodgkin Lymphoma (NHL )2017 - Market Insights, Epidemiology and Market Forecast, 2023 - Research and Markets

    Non-Hodgkin Lymphoma ( NHL )2017 - Market Insights, Epidemiology and Market Forecast, 2023 - Research and Markets

  2. Clinigen and Onxeo initiate Managed Access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)

    Clinigen and Onxeo initiate Managed Access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)

  3. Kraft Hockeyville™ USA Announces Top 10 Finalists; First Round of Public Voting Begins April 11

    Kraft Hockeyville™ USA Announces Top 10 Finalists; First Round of Public Voting Begins April 11

  4. SpotHero Acquires Leading Competitor Parking Panda, Securing Top Position in North American Parking Reservations

    SpotHero Acquires Leading Competitor Parking Panda, Securing Top Position in North American Parking Reservations

  5. NHL players will sit out 2018 Winter Olympics

    NHL players will sit out 2018 Winter Olympics

  6. Kite Completes Submission of U.S. Biologics License Application (BLA) for Axicabtagene Ciloleucel as the First CAR-T Therapy for the Treatment of Patients With Aggressive Non-Hodgkin Lymphoma (NHL )

    Kite Completes Submission of U.S. Biologics License Application (BLA) for Axicabtagene Ciloleucel as the First CAR-T Therapy for the Treatment of Patients With Aggressive Non-Hodgkin Lymphoma ( NHL )

  7. Sling TV Bolsters Spanish-Language Programming; Adds Three New Networks to ‘Best of Spanish TV’

    Sling TV Bolsters Spanish-Language Programming; Adds Three New Networks to ‘Best of Spanish TV’

  8. SHOWTIME® Arrives on Sling TV

    SHOWTIME® Arrives on Sling TV

  9. Kite Presents Ongoing Response Rate in Plenary Session from its Pivotal CAR-T Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma at the 2017 American Association of ...

    Kite Presents Ongoing Response Rate in Plenary Session from its Pivotal CAR-T Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma at the 2017 American Association of Cancer Research Annual Meeting

  10. UConn women's record 111-game win streak halted by OT loss to Mississippi State

    UConn women's record 111-game win streak halted by OT loss to Mississippi State

12

©2017 Morningstar Advisor. All right reserved.